Stay updated with breaking news from Pplev Qualcomm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Supreme Court in the US has declined Apple's bid for a hearing over two patents by chip-maker Qualcomm that alleged infringement of its technologies by the iPhone maker.
Addressing the type of prior art that may form the basis of an inter partes review IPR proceeding, the Federal Circuit vacated an unpatentability finding based on applicant admitted prior art in the challenged patent. Qualcomm Inc. v. Apple Inc.
Thursday, May 13, 2021 In Apple v. Qualcomm, Federal Circuit Finds No Standing to Challenge Validity of a Few Patents When Many Were Licensed The development timeline for small-molecule drugs and biologics is lengthy, estimated to take between 10 and 15 years. As a result, pharmaceutical companies need to consider freedom to operate issues long before they receive FDA approval or market their new product. These considerations might lead a company to take a license, seek to invalidate a competitor’s patent, or some combination of the two. The Patent Trial and Appeal Board (“PTA...